S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,023.00 +0.94% CRUDE 81.77 +3.57%
Next Bullish Trade
Sign in
ACTU

Actuate Therapeutics, Inc. ACTU

$1.44 -0.22 (-13.25%)
Pullback · -0.78σ
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · ACTU

Momentum reads · latest daily bar
Last
$1.44
-0.22 (-13.25%)
Mkt cap
$34M
Healthcare
RSI(14)
40.7
neutral
Stochastic %K
53.6
neutral
MFI(14)
73.2
neutral
ADX(14)
16.0
weak trend

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 — $-0.0B $-0.0B $-0.0B — —
2025-12-31 — $-0.0B $-0.0B $-0.0B — —
2025-09-30 — $-0.0B $-0.0B $-0.0B — —
2025-06-30 — $-0.0B $-0.0B $-0.0B — —
2025-03-31 — $-0.0B $-0.0B $-0.0B — —
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare ACTU vs peers

Line ACTU up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing ACTU no peers yet — add up to 4 below
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Add tickers to compare with ACTU

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 0 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

No earnings history available.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
ACTU ★ $0B — -1.7 — — 9.0 — — — -34.37%
LLY $1,051B 41.8 26.3 14.6 29.8 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 20.2 4.0 18.8% 2.0% 0.7% 4.57%
JNJ $609B 29.4 19.7 6.2 18.2 7.5 68.1% 6.6% -1.0% —
MRK $315B 35.9 13.2 4.8 12.2 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.1 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.7 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.3 19.5 4.4 21.4 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 55.6%

HolderShares% out
Bios Capital Management, LP 10,049,996 42.00%
Voss Capital, LP 1,725,000 7.21%
Blackrock Inc. 427,153 1.79%
Vanguard Capital Management LLC 400,529 1.67%
Geode Capital Management, LLC 228,331 0.95%
Connective Capital Management LLC 113,266 0.47%
Palogic Value Management, LP 100,000 0.42%
Northern Trust Corporation 97,851 0.41%
Texas Capital Bank Wealth Management 94,592 0.40%
State Street Corporation 66,030 0.28%

Insider activity · 90d

7 buys / 0 sells · ratio 7.0 · Finnhub

  • Zabrowski Dan BUY 15,000
  • Sawhney Roger BUY 15,000
  • Keyes Jason A BUY 15,000
  • Huber Martin H. Jr. BUY 15,000
  • Fletcher Aaron G.L. BUY 15,000
  • RONNEBERG AMY L BUY 15,000
  • THOMSON TODD S BUY 15,000

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$5.0
Mean
$9.9775
High
$14.91
Analysts
4
Recommendation distribution · period 2026-07-01
2
7
1
Revision trend (2026-04-01 → 2026-07-01): net 9 → 9 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
8-K 2026-07-17 CURRENT REPORT view ·
8-K 2026-05-22 CURRENT REPORT view ·
4 2026-05-22 Insider transaction (Form 4) view ·
4 2026-05-22 Insider transaction (Form 4) view ·
4 2026-05-22 Insider transaction (Form 4) view ·
4 2026-05-22 Insider transaction (Form 4) view ·
4 2026-05-22 Insider transaction (Form 4) view ·
4 2026-05-22 Insider transaction (Form 4) view ·
4 2026-05-22 Insider transaction (Form 4) view ·
10-Q 2026-05-14 FORM 10-Q FOR MAR 2026 view ·
8-K 2026-05-11 FORM 8-K view ·
8-K 2026-05-06 CURRENT REPORT view ·
DEF 14A 2026-04-06 DEF 14A view ·
4 2026-04-01 Insider transaction (Form 4) view ·
4 2026-04-01 Insider transaction (Form 4) view ·
4 2026-04-01 Insider transaction (Form 4) view ·
10-K 2026-03-26 FORM 10-K FOR DEC 2025 view ·
4 2026-02-13 Insider transaction (Form 4) view ·
8-K 2026-01-12 FORM 8-K view ·
4 2026-01-07 Insider transaction (Form 4) view ·
8-K 2025-11-28 CURRENT REPORT view ·
8-K 2025-11-21 FORM 8-K view ·
10-Q 2025-11-13 FORM 10-Q FOR SEP 2025 view ·
8-K 2025-09-10 CURRENT REPORT view ·
10-Q 2025-08-14 FORM 10-Q FOR JUN 2025 view ·
S-1 2025-07-25 REGISTRATION STATEMENT view ·
4 2025-06-30 OWNERSHIP DOCUMENT view ·
4 2025-06-30 OWNERSHIP DOCUMENT view ·
4 2025-06-30 OWNERSHIP DOCUMENT view ·
8-K 2025-06-26 CURRENT REPORT view ·
8-K 2025-06-05 CURRENT REPORT view ·
8-K 2025-06-02 FORM 8-K view ·
4 2025-05-23 Insider transaction (Form 4) view ·
8-K 2025-05-23 FORM 8-K view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
4 2025-05-23 Insider transaction (Form 4) view ·
10-Q 2025-05-15 FORM 10-Q FOR MAR 2025 view ·
8-K 2025-05-06 FORM 8-K view ·
DEF 14A 2025-04-08 DEFINITIVE PROXY view ·
4 2025-04-02 Insider transaction (Form 4) view ·
4 2025-04-02 Insider transaction (Form 4) view ·
4 2025-04-02 Insider transaction (Form 4) view ·
S-1 2025-03-28 REGISTRATION STATEMENT view ·
8-K 2025-03-28 FORM 8-K view ·
10-K 2025-03-13 FORM 10-K FOR 2024 view ·
8-K 2025-02-07 FORM 8-K view ·
8-K 2024-12-17 FORM 8-K view ·
10-Q 2024-11-13 FORM 10-Q FOR SEPT 2024 view ·
8-K 2024-11-12 FORM 8-K view ·
10-Q 2024-09-24 FORM 10-Q FOR JUNE 2024 view ·
8-K 2024-08-19 FORM 8-K view ·
4 2024-08-16 OWNERSHIP DOCUMENT view ·
4 2024-08-14 OWNERSHIP DOCUMENT view ·
4 2024-08-14 OWNERSHIP DOCUMENT view ·
4 2024-08-14 OWNERSHIP DOCUMENT view ·
4 2024-08-14 OWNERSHIP DOCUMENT view ·
4 2024-08-14 OWNERSHIP DOCUMENT view ·

About ACTU

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as neuroblastoma and pediatric leukemias. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. Actuate Therapeutics, Inc. was incorporated in 2015 and is headquartered in Fort Worth, Texas.

Options picks · ACTU

ITM + OTM ideas from the latest scan

Loading…

Congress trades · ACTU

STOCK Act disclosures

Loading…

SEC filings & insiders · ACTU

EDGAR · live

Loading…

Holders · ACTU

Institutions & insider activity

Loading…